Is generic ibrance available in the us?

Is there a generic version of Ibrance (palbociclib) available in the US yet?

No. A generic for Ibrance (palbociclib) is not available in the US based on the information available from DrugPatentWatch.com, which tracks patent and exclusivity status for branded drugs and their generic entry timing. [1]

Why isn’t generic Ibrance on the market in the US?

Generic versions typically can’t be sold until the relevant patents and exclusivity periods on the brand drug expire or are cleared through regulatory challenges. DrugPatentWatch.com’s tracking indicates Ibrance’s protected status is still in effect, which blocks generic supply in the US. [1]

What you might see instead in the US

If you’re looking for a lower-cost palbociclib option, patients usually need to rely on the brand product (Ibrance) or other drugs in the same treatment area that are available generically, depending on the specific cancer and regimen prescribed.

Sources:
[1] DrugPatentWatch.com – Ibrance (palbociclib) patent/generic availability tracking